40 research outputs found
Biological evaluation of intervertebral disc cells in different formulations of gellan gum-based hydrogels
First published online: 2012Gellan gum (GG)-based hydrogels are advantageous in tissue engineering not only due to their ability
to retain large quantities of water and provide a similar environment to that of natural extracellular
matrix (ECM), but also because they can gelify in situ in seconds. Their mechanical properties can be
fine-tuned to mimic natural tissues such as the nucleus pulposus (NP). This study produced different
formulations of GG hydrogels by mixing varying amounts of methacrylated (GG-MA) and high-acyl
gellan gums (HA-GG) for applications as acellular and cellular NP substitutes. The hydrogels were
physicochemically characterized by dynamic mechanical analysis. Degradation and swelling abilities
were assessed by soaking in a phosphate buffered saline solution for up to 170 h. Results showed that
as HA-GG content increased, the modulus of the hydrogels decreased. Moreover, increases in HA-GG
content induced greater weight loss in the GG-MA/HA-GG formulation compared to GG-MA hydrogel.
Potential cytotoxicity of the hydrogel was assessed by culturing rabbit NP cells up to 7 days. An MTS
assay was performed by seeding rabbit NP cells onto the surface of 3D hydrogel disc formulations.
Viability of rabbit NP cells encapsulated within the different hydrogel formulations was also
evaluated by Calcein-AM and ATP assays. Results showed that tunable GG-MA/HA-GG hydrogels were
non-cytotoxic and supported viability of rabbit NP cells.The authors thank the Portuguese Foundation for Science and Technology (FCT) for financial support through POCTI and FEDER programmes. This work was also conducted with the support of the European Union funded Collaborative Project Disc Regeneration (NMP3-LA-2008-213904), MBC(A04003) and the World Class University project (R31-20029)
Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations : design, characterisation, toxicity and transcorneal permeation studies
This study was aimed at preparing, characterising and evaluating in situ gel formulations based on a blend of two hydrophilic polymers i.e. poloxamer 407 (P407) and poloxamer 188 (P188) for a sustained ocular delivery of ketorolac tromethamine (KT). Drug-polymer interaction studies were performed using {DSC} and FT-IR. The gelation temperature (Tsol-gel), gelation time, rheological behaviour, mucoadhesive characteristics of these gels, transcorneal permeation and ocular irritation as well as toxicity was investigated. {DSC} and FT-IR studies revealed that there may be electrostatic interactions between the drug and the polymers used. {P188} modified the Tsol/gel of {P407} bringing it close to eye temperature (35°C) compared with the formulation containing {P407} alone. Moreover, gels that comprised {P407} and {P188} exhibited a pseudoplastic behaviour at different concentrations. Furthermore, mucoadhesion study using mucin discs showed that in situ gel formulations have good mucoadhesive characteristics upon increasing the concentration of P407. When comparing formulations {PP11} and PP12, the work of adhesion decreased significantly (P < 0.001) from 377.9 ± 7.79 mN.mm to 272.3 ± 6.11 mN.mm. In vitro release and ex vivo permeation experiments indicated that the in situ gels were able to prolong and control {KT} release as only 48 of the {KT} released within 12 h. In addition, the HET-CAM and {BCOP} tests confirmed the non-irritancy of {KT} loaded in situ gels, and HET-CAM test demonstrated the ability of ocular protection against strongly irritant substances. {MTT} assay on primary corneal epithelial cells revealed that in situ gel formulations loaded with {KT} showed reasonable and acceptable percent cell viability compared with control samples
Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel
Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma
In vitro and in vivo evaluation of an intraocular implant for glaucoma treatment
Implantable disks for glaucoma treatment were prepared by blending poly(ɛ-caprolactone), PCL, poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) and dorzolamide. Their in vivo performance was assessed by their capacity to decrease intraocular pressure (IOP) in normotensive and hypertensive eyes. Drug mapping showed that release was complete from blend disks and the low molecular weight (MW) PCL after 1 month in vivo. The high MW PCL showed non-cumulative release rates above the therapeutic level during 3 months in vitro. In vivo, the fibrous capsule formation around the implant controls the drug release, working as a barrier membrane. Histologic analysis showed normal foreign body reaction response to the implants. In normotensive eyes, a 20% decrease in IOP obtained with the disks during 1 month was similar to Trusopt® eyedrops treatment. In hypertensive eyes, the most sustained decrease was shown by the high MW PCL (40% after 1 month, 30% after 2 months). It was shown that the implants can lower IOP in sustained manner in a rabbit glaucoma model